Molly Metz

In its recent petition to the U.S. Supreme Court, Google argues that patents can be invalid at any time, even decades after issuance, and therefore should remain open to inter partes review (IPR) challenges, regardless of age or how long they have been relied upon. At first glance, this sounds like a defense of patent quality. Coming from one of the most frequent users of the Patent Trial and Appeal board (PTAB) over the past decade — and arriving just as the U.S. Patent and Trademark Office’s (USPTO’s) “settled expectations” doctrine begins to limit late-stage IPR challenges — it raises a sharper question: why now?

In a recent Substack post discussing Patent Trial and Appeal Board (PTAB) policy and current U.S. Patent and Trademark Office (USPTO) reforms, former USPTO Deputy Solicitor Thomas Krause referenced my PTAB case as part of his broader argument. Because my case was cited in that discussion, the factual record matters… My case does not support the claim that the PTAB primarily exists to correct examiner errors or clean up patents issued over missed prior art.

Timing is everything in the world of American innovation. On September 16, 2025, I hand delivered a petition for rulemaking to the U.S. Patent and Trademark Office (USPTO) seeking a simple, long-overdue fix: clarify by rule that “cancellation” of a patent claim means the end of rights prospectively, not erasure of decades of hard-earned reliance, contracts, and value. After living this process, I know firsthand how timing and retroactivity can destroy the lives and businesses of those who play by the rules.

As President Trump’s executive order mandating federal employees to return to the office ignites national debate, it underscores a glaring irony for inventors like me—those whose lives and businesses have already been upended by a remote government system that wields immense power with little accountability.

I was told that elected officials count on—in fact, they need—constituent input to be effective legislators. After my patents were unjustly cancelled at the Patent Trial and Appeal Board (PTAB), I started the journey to do this very thing. Since January of 2022, I have visited Congress and the Senate two dozen times. I have visited over 200 offices telling my story and advocating for the “little” inventors, like me.